Tumor suppressor WWOX regulates glucose metabolism via HIF1α modulation

Cell Death and Differentiation

Volumn 21, Issue 11, 2014, Pages 1805-1814

  Abu Remaileh, M ^a   Aqeilan, R I ^a,b  

^a HEBREW UNIVERSITY   (Israel)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXIDOREDUCTASE; TUMOR SUPPRESSOR PROTEIN; WWOX PROTEIN, HUMAN; WWOX PROTEIN, MOUSE;

ANIMAL; GENETICS; GLYCOLYSIS; HUMAN; METABOLISM; MITOCHONDRION; MOUSE; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL LINE, TUMOR; GENES, TUMOR SUPPRESSOR; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; GLYCOLYSIS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; MITOCHONDRIA; OXIDOREDUCTASES; TUMOR SUPPRESSOR PROTEINS;

EID: 84932091996     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2014.95     Document Type: Article

References (48)

1. Bednarek AK, Keck-Waggoner CL, Daniel RL, Laflin KJ, Bergsagel PL, Kiguchi K et al. WWOX, the FRA16D gene, behaves as a suppressor of tumor growth. Cancer Res 2001; 61: 8068-8073.
2. Aqeilan RI, Croce CM. WWOX in biological control and tumorigenesis. J Cell Physiol 2007; 212: 307-310.
3. Gardenswartz A, Aqeilan RI. WW domain-containing oxidoreductase's role in myriad cancers: clinical significance and future implications. Exp Biol Med 2014; 239: 253-263.
4. Aqeilan RI, Trapasso F, Hussain S, Costinean S, Marshall D, Pekarsky Y et al. Targeted deletion of Wwox reveals a tumor suppressor function. Proc Natl Acad Sci USA 2007; 104: 3949-3954.
5. Aqeilan RI, Hassan MQ, de Bruin A, Hagan JP, Volinia S, Palumbo T et al. The WWOX tumor suppressor is essential for postnatal survival and normal bone metabolism. J Biol Chem 2008; 283: 21629-21639.
6. Ludes-Meyers JH, Kil H, Parker-Thornburg J, Kusewitt DF, Bedford MT, Aldaz CM. Generation and characterization of mice carrying a conditional allele of the Wwox tumor suppressor gene. PLoS One 2009; 4: e7775.
7. Abdeen SK, Del Mare S, Hussain S, Remaileh M.A, Salah Z, Hagan J et al. Conditional inactivation of the mouse Wwox tumor suppressor gene recapitulates the null phenotype. J Cell Physiol 2012; 228: 1377-1382.
8. Abdeen SK, Salah Z, Maly B, Smith Y, Tufail R, Abu-Odeh M et al. Wwox inactivation enhances mammary tumorigenesis. Oncogene 2011; 30: 3900-3906.
9. Aqeilan RI, Hagan JP, Aqeilan HA, Pichiorri F, Fong LY, Croce CM. Inactivation of the Wwox gene accelerates forestomach tumor progression in vivo. Cancer Res 2007; 67: 5606-5610.
10. Aqeilan RI, Palamarchuk A, Weigel RJ, Herrero JJ, Pekarsky Y, Croce CM. Physical and functional interactions between the Wwox tumor suppressor protein and the AP-2gamma transcription factor. Cancer Res 2004; 64: 8256-8261.
11. Aqeilan RI, Donati V, Gaudio E, Nicoloso MS, Sundvall M, Korhonen A et al. Association of Wwox with ErbB4 in breast cancer. Cancer Res 2007; 67: 9330-9336.
12. Gaudio E, Palamarchuk A, Palumbo T, Trapasso F, Pekarsky Y, Croce CM et al. Physical association with WWOX suppresses c-Jun transcriptional activity. Cancer Res 2006; 66: 11585-11589.
13. Salah Z, Aqeilan R, Huebner K. WWOX gene and gene product: tumor suppression through specific protein interactions. Future Oncol 2010; 6: 249-259.
14. Abu-Odeh M, Bar-Mag T, Huang H, Kim T, Salah Z, Abdeen SK et al. Characterizing WW domain interactions of tumor suppressor WWOX reveals its association with multiprotein networks. J Biol Chem 2014; 289: 8865-8880.
15. O'Keefe LV, Colella A, Dayan S, Chen Q, Choo A, Jacob R et al. Drosophila orthologue of WWOX, the chromosomal fragile site FRA16D tumour suppressor gene, functions in aerobic metabolism and regulates reactive oxygen species. Hum Mol Genet 2011; 20: 497-509.
16. Dayan S, O'Keefe LV, Choo A, Richards RI. Common chromosomal fragile site FRA16D tumor suppressor WWOX gene expression and metabolic reprograming in cells. Genes Chromosomes Cancer 2013; 52: 823-831.
17. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70.
18. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674.
19. Lunt SY, Vander Heiden MG. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol 2011; 27: 441-464.
20. Warburg O. On the origin of cancer cells. Science 1956; 123: 309-314.
21. Warburg O. On respiratory impairment in cancer cells. Science 1956; 124: 269-270.
22. Lum JJ, Bui T, Gruber M, Gordan JD, DeBerardinis RJ, Covello KL et al. The transcription factor HIF-1alpha plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis. Genes Dev 2007; 21: 1037-1049.
23. Weidemann A, Johnson RS. Biology of HIF-1alpha. Cell Death Differ 2008; 15: 621-627.
24. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 2008; 7: 11-20.
25. Jones RG, Thompson CB. Tumor suppressors and cell metabolism: a recipe for cancer growth. Genes Dev 2009; 23: 537-548.
26. Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 2006; 3: 187-197.
27. Le A, Lane AN, Hamaker M, Bose S, Gouw A, Barbi J et al. Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metab 2012; 15: 110-121.
28. Zhao Y, Butler EB, Tan M. Targeting cellular metabolism to improve cancer therapeutics. Cell Death Dis 2013; 4: e532.
29. Fong GH, Takeda K. Role and regulation of prolyl hydroxylase domain proteins. Cell Death Differ 2008; 15: 635-641.
30. Aragones J, Fraisl P, Baes M, Carmeliet P. Oxygen sensors at the crossroad of metabolism. Cell Metab 2009; 9: 11-22.
31. Zhong L, D'Urso A, Toiber D, Sebastian C, Henry RE, Vadysirisack DD et al. The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell 2010; 140: 280-293.
32. Sebastian C, Zwaans BM, Silberman DM, Gymrek M, Goren A, Zhong L et al. The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism. Cell 2012; 151: 1185-1199.
33. Cha ST, Chen PS, Johansson G, Chu CY, Wang MY, Jeng YM et al. MicroRNA-519c suppresses hypoxia-inducible factor-1alpha expression and tumor angiogenesis. Cancer Res 2010; 70: 2675-2685.
34. Taguchi A, Yanagisawa K, Tanaka M, Cao K, Matsuyama Y, Goto H et al. Identification of hypoxia-inducible factor-1 alpha as a novel target for miR-17-92 microRNA cluster. Cancer Res 2008; 68: 5540-5545.
35. Puissegur MP, Mazure NM, Bertero T, Pradelli L, Grosso S, Robbe-Sermesant K et al. miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity. Cell Death Differ 2011; 18: 465-478.
36. Grimm C, Willmann G. Hypoxia in the eye: a two-sided coin. High Alt Med Biol 2012; 13: 169-175.
37. Zhang H, Qian DZ, Tan YS, Lee K, Gao P, Ren YR et al. Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth. Proc Natl Acad Sci USA 2008; 105: 19579-19586.
38. Yoshida T, Zhang H, Iwase T, Shen J, Semenza GL, Campochiaro PA. Digoxin inhibits retinal ischemia-induced HIF-1alpha expression and ocular neovascularization. FASEB J 2010; 24: 1759-1767.
39. Gayed BA, O'Malley KJ, Pilch J, Wang Z. Digoxin inhibits blood vessel density and HIF-1a expression in castration-resistant C4-2 xenograft prostate tumors. Clin Transl Sci 2012; 5: 39-42.
40. Wei H, Bedja D, Koitabashi N, Xing D, Chen J, Fox-Talbot K et al. Endothelial expression of hypoxia-inducible factor 1 protects the murine heart and aorta from pressure overload by suppression of TGF-beta signaling. Proc Natl Acad Sci USA 2012; 109: E841-E850.
41. Salah Z, Bar-mag T, Kohn Y, Pichiorri F, Palumbo T, Melino G et al. Tumor suppressor WWOX binds to DeltaNp63alpha and sensitizes cancer cells to chemotherapy. Cell Death Dis 2013; 4: e480.
42. Del Mare S, Salah Z, Aqeilan RI. WWOX: its genomics, partners, and functions. J Cell Biochem 2009; 108: 737-745.
43. Chen Q, Vazquez EJ, Moghaddas S, Hoppel CL, Lesnefsky EJ. Production of reactive oxygen species by mitochondria: central role of complex III. J Biol Chem 2003; 278: 36027-36031.
44. Hagele S, Behnam B, Borter E, Wolfe J, Paasch U, Lukashev D et al. TSGA10 prevents nuclear localization of the hypoxia-inducible factor (HIF)-1alpha. FEBS Lett 2006; 580: 3731-3738.
45. Pientka FK, Hu J, Schindler SG, Brix B, Thiel A, Johren O et al. Oxygen sensing by the prolyl-4-hydroxylase PHD2 within the nuclear compartment and the influence of compartmentalisation on HIF-1 signalling. J Cell Sci 2012; 125(Pt 21): 5168-5176.
46. Rankin EB, Giaccia AJ. The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ 2008; 15: 678-685.
47. Kaplon J, Zheng L, Meissl K, Chaneton B, Selivanov VA, Mackay G et al. A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence. Nature 2013; 498: 109-112.
48. Wolf A, Agnihotri S, Micallef J, Mukherjee J, Sabha N, Cairns R et al. Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme. J Exp Med 2011; 208: 313-326.